The existing invention relates to pharmaceutical compositions of DPP IV inhibitors by having an amino team, their preparation and their use to deal with diabetic issues mellitus. In Tradjenta’s clinical trials, the next weight changes had been observed depending on how Tradjenta was applied: Depending on your symptoms and https://weightlossdrugozempic53187.blogspothub.com/23676704/facts-about-generic-linagliptin-india-revealed